By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


3SBio Inc. 

3 A1, Road 10
Economy & Technology Development Zone
Shenyang    110027  China
Phone: 86-24-2581-1820 Fax:


Company News
3SBio Inc. (SSRX) Acquires Control Of CP Guojian In $213 Million Deal 12/1/2015 11:07:08 AM
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For ALT-P7, An Antibody-Drug Conjugate Targeting HER2 With Alteogen 10/12/2015 6:20:33 AM
3SBio Inc. (SSRX) Selected As A Constituent Of The Hang Seng Composite LargeCap & MidCap Index 8/17/2015 9:33:36 AM
Week In Review: 3SBio Inc. (SSRX) Acquires Wansheng Pharma For $85 Million 7/27/2015 7:50:28 AM
3SBio Inc. (SSRX) Acquires Zhejiang Wansheng Pharmaceutical 7/24/2015 7:54:14 AM
Week In Review: 3SBio Inc. (SSRX) Snags Global Rights To mAb For Arthritis 6/29/2015 9:43:19 AM
3SBio Inc. (SSRX) Acquires Global Rights to Bay Area Apexigen’s Anti-TNF mAb 6/22/2015 7:15:01 AM
Week In Review: 3SBio Inc. (SSRX) Rises 5% After $711 Million IPO 6/15/2015 9:10:26 AM
3SBio Inc. (SSRX) Climbs 5% In First Trading Day In Hong Kong 6/11/2015 2:12:56 PM
Week In Review: 3SBio Inc. (SSRX) To Stage $712 Million Hong Kong IPO 6/1/2015 9:55:57 AM